138 related articles for article (PubMed ID: 37981531)
21. Genetic variants in the LPL and GPIHBP1 genes, in patients with severe hypertriglyceridaemia, detected with high resolution melting analysis.
Ariza MJ; Pérez-López C; Almagro F; Sánchez-Tévar AM; Muñiz-Grijalvo O; Álvarez-Sala Walter LA; Rioja J; Sánchez-Chaparro MÁ; Valdivielso P
Clin Chim Acta; 2020 Jan; 500():163-171. PubMed ID: 31669931
[TBL] [Abstract][Full Text] [Related]
22. Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men.
Matsumoto R; Tsunekawa K; Shoho Y; Yanagawa Y; Kotajima N; Matsumoto S; Araki O; Kimura T; Nakajima K; Murakami M
Lipids Health Dis; 2019 Apr; 18(1):84. PubMed ID: 30947712
[TBL] [Abstract][Full Text] [Related]
23. A case of hyperchylomicronemia associated with GPIHBP1 autoantibodies and fluctuating thyroid autoimmune disease.
Nozue T; Tada H; Murakami M; Michishita I
J Clin Lipidol; 2023; 17(1):68-72. PubMed ID: 36402671
[TBL] [Abstract][Full Text] [Related]
24. Familial chylomicronemia syndrome: case reports of siblings with deletions of the GPIHBP1 gene.
Kim KY; Heo YJ; Ko JM; Lee YA; Shin CH; Ki CS; Lee YJ
BMC Endocr Disord; 2024 Apr; 24(1):47. PubMed ID: 38622573
[TBL] [Abstract][Full Text] [Related]
25. A novel NanoBiT-based assay monitors the interaction between lipoprotein lipase and GPIHBP1 in real time.
Shetty SK; Walzem RL; Davies BSJ
J Lipid Res; 2020 Apr; 61(4):546-559. PubMed ID: 32029511
[TBL] [Abstract][Full Text] [Related]
26. GPIHBP1 autoantibody syndrome during interferon β1a treatment.
Eguchi J; Miyashita K; Fukamachi I; Nakajima K; Murakami M; Kawahara Y; Yamashita T; Ohta Y; Abe K; Nakatsuka A; Mino M; Takase S; Okazaki H; Hegele RA; Ploug M; Hu X; Wada J; Young SG; Beigneux AP
J Clin Lipidol; 2019; 13(1):62-69. PubMed ID: 30514621
[TBL] [Abstract][Full Text] [Related]
27. Structure of lipoprotein lipase in complex with GPIHBP1.
Arora R; Nimonkar AV; Baird D; Wang C; Chiu CH; Horton PA; Hanrahan S; Cubbon R; Weldon S; Tschantz WR; Mueller S; Brunner R; Lehr P; Meier P; Ottl J; Voznesensky A; Pandey P; Smith TM; Stojanovic A; Flyer A; Benson TE; Romanowski MJ; Trauger JW
Proc Natl Acad Sci U S A; 2019 May; 116(21):10360-10365. PubMed ID: 31072929
[TBL] [Abstract][Full Text] [Related]
28. A lipoprotein lipase-GPI-anchored high-density lipoprotein-binding protein 1 fusion lowers triglycerides in mice: Implications for managing familial chylomicronemia syndrome.
Nimonkar AV; Weldon S; Godbout K; Panza D; Hanrahan S; Cubbon R; Xu F; Trauger JW; Gao J; Voznesensky A
J Biol Chem; 2020 Mar; 295(10):2900-2912. PubMed ID: 31645434
[TBL] [Abstract][Full Text] [Related]
29. Hypertriglyceridemia in Apoa5-/- mice results from reduced amounts of lipoprotein lipase in the capillary lumen.
Yang Y; Beigneux AP; Song W; Nguyen LP; Jung H; Tu Y; Weston TA; Tran CM; Xie K; Yu RG; Tran AP; Miyashita K; Nakajima K; Murakami M; Chen YQ; Zhen EY; Kim JR; Kim PH; Birrane G; Tontonoz P; Ploug M; Konrad RJ; Fong LG; Young SG
J Clin Invest; 2023 Dec; 133(23):. PubMed ID: 37824203
[TBL] [Abstract][Full Text] [Related]
30. Anti-GPIHBP1 Antibody-Positive Autoimmune Hyperchylomicronemia and Immune Thrombocytopenia.
Tanaka K; Koseki M; Kato H; Miyashita K; Okada T; Kanno K; Saga A; Chang J; Omatsu T; Inui H; Ohama T; Nishida M; Yamashita S; Sakata Y
J Atheroscler Thromb; 2023 Jan; 30(1):100-104. PubMed ID: 35185060
[TBL] [Abstract][Full Text] [Related]
31. Deletion of GPIHBP1 causing severe chylomicronemia.
Rios JJ; Shastry S; Jasso J; Hauser N; Garg A; Bensadoun A; Cohen JC; Hobbs HH
J Inherit Metab Dis; 2012 May; 35(3):531-40. PubMed ID: 22008945
[TBL] [Abstract][Full Text] [Related]
32. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
[TBL] [Abstract][Full Text] [Related]
33. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
[TBL] [Abstract][Full Text] [Related]
34. Novel mutations in the GPIHBP1 gene identified in 2 patients with recurrent acute pancreatitis.
Ariza MJ; Martínez-Hernández PL; Ibarretxe D; Rabacchi C; Rioja J; Grande-Aragón C; Plana N; Tarugi P; Olivecrona G; Calandra S; Valdivielso P
J Clin Lipidol; 2016; 10(1):92-100.e1. PubMed ID: 26892125
[TBL] [Abstract][Full Text] [Related]
35. Severe hypertriglyceridemia in a patient heterozygous for a lipoprotein lipase gene allele with two novel missense variants.
Kassner U; Salewsky B; Wühle-Demuth M; Szijarto IA; Grenkowitz T; Binner P; März W; Steinhagen-Thiessen E; Demuth I
Eur J Hum Genet; 2015 Sep; 23(9):1259-61. PubMed ID: 25585702
[TBL] [Abstract][Full Text] [Related]
36. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
[TBL] [Abstract][Full Text] [Related]
37. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.
Davies BS; Beigneux AP; Barnes RH; Tu Y; Gin P; Weinstein MM; Nobumori C; Nyrén R; Goldberg I; Olivecrona G; Bensadoun A; Young SG; Fong LG
Cell Metab; 2010 Jul; 12(1):42-52. PubMed ID: 20620994
[TBL] [Abstract][Full Text] [Related]
38. The lipoprotein lipase that is shuttled into capillaries by GPIHBP1 enters the glycocalyx where it mediates lipoprotein processing.
Song W; Beigneux AP; Weston TA; Chen K; Yang Y; Nguyen LP; Guagliardo P; Jung H; Tran AP; Tu Y; Tran C; Birrane G; Miyashita K; Nakajima K; Murakami M; Tontonoz P; Jiang H; Ploug M; Fong LG; Young SG
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2313825120. PubMed ID: 37871217
[TBL] [Abstract][Full Text] [Related]
39. A disordered acidic domain in GPIHBP1 harboring a sulfated tyrosine regulates lipoprotein lipase.
Kristensen KK; Midtgaard SR; Mysling S; Kovrov O; Hansen LB; Skar-Gislinge N; Beigneux AP; Kragelund BB; Olivecrona G; Young SG; Jørgensen TJD; Fong LG; Ploug M
Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E6020-E6029. PubMed ID: 29899144
[TBL] [Abstract][Full Text] [Related]
40. An upstream enhancer regulates
Allan CM; Heizer PJ; Tu Y; Sandoval NP; Jung RS; Morales JE; Sajti E; Troutman TD; Saunders TL; Cusanovich DA; Beigneux AP; Romanoski CE; Fong LG; Young SG
J Lipid Res; 2019 Apr; 60(4):869-879. PubMed ID: 30598475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
